Bafna Pharmaceuticals Limited (BAFNAPH) fundamentals
Bafna Pharmaceuticals Limited is a listed company in Pharmaceuticals & Biotechnology, part of the Healthcare sector, listed on the NSE as BAFNAPH (ISIN INE878I01022). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Bafna Pharmaceuticals Limited does
Bafna Pharmaceuticals Limited is an India-based company, which is engaged in manufacturing of pharmaceutical formulations. The Company exports its products to the Europe, the United Kingdom, Australia, Sri Lanka, Africa, and Commonwealth countries.
Valuation and market data
| Last close | ₹301.45 |
|---|---|
| Market capitalisation | ₹713 crore |
| Enterprise value | ₹734 crore |
| P/E (TTM) | 64.28 |
| Price to book | 7.42 |
| Price to sales (TTM) | 2.79 |
| Book value per share | ₹40.63 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Listed since | Thu Feb 27 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹155 crore | ₹11 crore | ₹11 crore | 4.69 |
| Mar 2025 | ₹149 crore | ₹4 crore | ₹4 crore | 1.76 |
| Mar 2024 | ₹156 crore | ₹7 crore | ₹7 crore | 3.11 |
| Mar 2023 | ₹119 crore | ₹12 crore | ₹11 crore | 4.79 |
| Mar 2022 | ₹87 crore | ₹5 crore | ₹5 crore | 2.19 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 75.0% |
|---|---|
| Foreign institutions (FII) | 9.3% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 15.7% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.